MedPath
NMPA Approval

Topotecan Hydrochloride for Injection

国药准字H20052432

July 27, 2020

国药准字H20052432

Drug Information

注射用盐酸托泊替康

胜城

胜城

注射剂

2mg(按C23H23N3O5计算)

化学药品

July 27, 2020

Company Information

Applicant Company

湖北省黄石市金山大道东69号

Manufacturing Company

湖北省黄石市金山大道东69号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸托泊替康 - NMPA 批准文号 | MedPath